Ledger.Open graph →
SEC Form D · filed September 7, 2018

Epharmix, Inc

Offering
$3.0M
Sold
$1.9M
Exemption
Rule 506(b)
Industry
Other Technology
Location
ST. LOUIS, MO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Max Bricklin · St. Louis, MODirectorBlake Marggraff · St. Louis, MOExec · Director · PromoterMark Bakken · St. Louis, MODirectorAvik Som · St. Louis, MOExec · Director · PromoterBlake Marggraff · St. Louis, MOExec · Director · PromoterMax Bricklin · St. Louis, MODirectorMark Bakken · St. Louis, MODirectorAvik Som · St. Louis, MOExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗